Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Depreciation & Amortization (CF) (2024 - 2025)

Hinge Health (HNGE) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 10.47% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, up 26.54% year-over-year, with the annual reading at $5.1 million for FY2025, 13.73% down from the prior year.
  • Depreciation & Amortization (CF) hit $1.2 million in Q4 2025 for Hinge Health, down from $1.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.4 million in Q3 2024 to a low of $300000.0 in Q2 2025.